Trial Begins of Nasal Vaccine for Alzheimer’s Disease
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center forContinue Reading